Nursing home-acquired pneumonia: A review of risk factors and therapeutic approaches

Current Medical Research and Opinion

Volumn 26, Issue 12, 2010, Pages 2707-2714

  El Solh, Ali A ^a   Niederman, Mike S ^b,c   Drinka, Paul ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Nursing home; Pneumonia; Scoring; Treatment

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; NEUROLEPTIC AGENT; OSELTAMIVIR; PENICILLIN G; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN; ZANAMIVIR;

AGE; ANTICHOLINERGIC EFFECT; CHLAMYDOPHILA PNEUMONIAE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DYSPHAGIA; GENDER; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; INFLUENZA; INFLUENZA VIRUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NURSING HOME; NURSING HOME ACQUIRED PNEUMONIA; PNEUMONIA; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; CROSS INFECTION; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NURSING HOMES; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 78349265283     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.530154     Document Type: Review

References (69)

1. Muder RR, Aghababian RV, Loeb MR, et al. Nursing home-acquired pneumonia: an emergency department treatment algorithm. Curr Med Res Opin 2004;20:1309-20
2. El Solh AA, Akinnusi ME, Alfarah Z, et al. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc 2009;57:1030-5
3. Marrie TJ. Pneumonia in the long-term-care facility. Infect Control Hosp Epidemiol 2002;23:159-64
4. Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997;45:50-5
5. Loeb M. Epidemiology of community- and nursing home-acquired pneumonia in older adults. Expert Rev Anti Infect Ther 2005;3:263-70
6. Brito V, Niederman MS. How can we improve the management and outcome of pneumonia in the elderly? Eur Respir J 2008;32:12-14
7. Hutt E, Ruscin JM, Corbett K, et al. A multifaceted intervention to implement guidelines improved treatment of nursing home-acquired pneumonia in a state veterans home. J Am Geriatr Soc 2006;54:1694-700
8. Hutt E, Reznickova N, Morgenstern N, et al. Improving care for nursing home-acquired pneumonia in a managed care environment. Am J Manag Care 2004;10:681-6
9. Loeb M, McGeer A, McArthur M, et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159:2058-64
10. Vergis EN, Brennen C, Wagener M, et al. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001;161:2378-81
11. Beck-Sague C, Banerjee S, Jarvis WR. Infectious diseases and mortality among nursing home residents. Am J Public Health 1993;83:1739-42
12. Magaziner J, Tenney JH, DeForge B, et al. Prevalence and characteristics of nursing-home acquired infections in the aged. J Am Geriatr Soc 1991; 39:1071-8
13. Jacobson C, Strausbaugh LJ. Incidence and impact of infection in the nursing home care unit. Am J Infect Control 1990;18:151-9
14. Setia U, Serventi I, Lorenz P. Nosocomial infections among patients in the long-term care facility: spectrum, prevalence, and risk factors. Am J Infect Control 1998;13:57-62
15. Rantanen TK, Salo JA. Gastroesophogeal reflux disease as a cause of death: analysis of fatal cases under conservative treatment. Scand J Gastroenterol 1999;34:229-33
16. Quagliarello V, Ginter S, Han L, et al. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005;40:1-6
17. Knol W, van Marum R, Jansen P, et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008; 56:661-6
18. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008;149: 391-8
19. Eurich D, Sadowski C, Simpson S, et al. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med 2010; 123:47-53
20. Mylotte JM. Nursing home-acquired pneumonia: update on treatment options. Drugs Aging 2006;23:377-90
21. Loeb M. Pneumonia in older persons. Clin Infect Dis 2003;37:1335-9
22. Medina-Walpole AM, Katz PR. Nursing home-acquired pneumonia. J Am Geriatr Soc 1999;47:1005-15
23. Kothe H, Bauer T, Marre R, et al. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008;32:139-46
24. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-8
25. Muder R. Penumonia in residents of long-term care facilities: epidemiology, etiology, management and prevention. Am J Med 1998;105:319-30
26. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:1214-18
27. Seenivasan MH, Yu VL, Muder RR. Legionnaires' disease in long-term care facilities: overview and proposed solutions. J Am Geriatr Soc 2005; 53:875-80
28. Maruyama T, Niederman MS, Kobayashi T, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med 2008;102:1287-95
29. Mills K, Graham AC, Winslow BT, et al. Treatment of nursing home-acquired pneumonia. Am Fam Physician 2009;79:976-82
30. Ellis SE, Coffey CS, Mitchel Jr EF, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003;51:761-7
31. Falsey AR, Dallal GE, Formica MA, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc 2008;56:1281-5
32. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis 2010;50:747-51
33. El-Solh AA, Sikka P, Ramadan F, et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001;163:645-51
34. El Solh AA, Pietrantoni C, Bhat A, et al. Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 2004; 39:474-80
35. Drinka PJ. Long term tracking of methicillin-resistant Staphylococcus aureus in a large skilled nursing facility. J Am Geriatr Soc 2004;52:1968
36. El Solh A, Aquilina A, Dhillon R, et al. Antimicrobial treatment failure in institutionalized elderly with severe pneumonia. Am J Respir Crit Care Med 2002;166:1038-43
37. Polverino E, Dambrava P, Cilló niz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010;65:354-9. Erratum in: Thorax 2010;65:844
38. Kollef M, Shorr A, Tabak Y, et al. Epidemiology and outcomes of health-care associated pneumonia: results from a large US database of culture positive pneumonia. Chest 2005;128:3854-62
39. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008;168:2205-10
40. Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract 2002;51:709-16
41. Bentley DW, Bradley S, High K, et al. Practice guidelines for evaluation of fever and infections in long-term care facilities. Clin Infect Dis 2000;31:640-53
42. El Solh AA. Nursing home-acquired pneumonia. Semin Respir Crit Care Med 2009;30:16-25
43. El Solh A, Niderman M, Drinka P. Management of pneumonia in the nursing home. Chest (In Press)
44. Dosa D. Should I hospitalize my resident with nursing home-acquired pneumonia? J Am Med Dir Assoc 2006;7(3 Suppl):S74-80, 73
45. Fried TR, Gillick MR, Lipsitz LA. Whether to transfer? Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J Gen Intern Med 1995;10:246-50
46. Intrator O, Castle NG, Mor V. Facility characteristics associated with hospi-talization of nursing home residents: Results of a national study. Med Care 1999;37:228-37
47. Mehr DR, Zweig SC, Kruse RL, et al. Mortality from lower respiratory infection in nursing home residents. A pilot prospective community-based study. J Fam Pract 1998;47:298-304
48. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336: 243-50
49. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82
50. Mylotte JM, Naughton B, Saludades C, et al. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. J Am Geriatr Soc 1998; 46:1538-44
51. Myint PK, Kamath AV, Vowler SL, et al. The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalized elderly patients aged 65 years and over: a prospective observational cohort study. Age Ageing 2005;34:75-7
52. Myint P, Kamath A, Vowler S, et al. British Thoracic Society. Severity assessment criteria recommended by the British Thoracic Society for community-acquired pneumonia and older patients. Should SOAR criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286-91
53. El Solh A, Alhajhusain A, Abou Jaoude P, et al. Validity of severity of scores in hospitalized patients with nursing home acquired pneumonia. Chest 2010 (In Press)
54. Torres OH, Munoz J, Ruiz D, et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am Geriatr Soc 2004;52: 1603-9
55. Van Der Steen JT, Mehr DR, Kruse RL, et al. Dementia, lower respiratory tract infection, and mortality. J Am Med Dir Assoc 2007;8:396-403
56. Mandell LA, Bartlett JG, Dowell SF, et al.; for the Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37: 1405-33
57. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society: The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 2000;31:383-421
58. Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999;159:2562-72
59. Cunha BA, Domenico PD, Cunha CB. Pharmacodynamics of doxycycline. Clin Microbiol Infect 2000;6:270-3
60. Pettersson E, Vernby A, Molstad S, et al. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis 2008; 40:393-8
61. American Thoracic Society Documents. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
62. El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167:1650-4
63. Mylotte JM. Treatment of nursing home-acquired pneumonia: dogma vs. data. Am Fam Physician 2009;79:945-8
64. El Solh A, Akinnusi M, Alfarah Z, et al. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home acquired pneumonia. J Am Geriatr Soc 2009;57:1030-5
65. Ruf B, Szucs T. Reducing the burden of influenza associated complications with antiviral therapy. Infection 2009;37:186-96
66. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44
67. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005;127:1260-70
68. Frei CR, Restrepo MI, Mortensen EM, et al. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med 2006;119:865-71
69. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-72